Bibliometric Analysis on Study of Oridonin Based on CNKI Click Copy

Bibliometric Analysis on Study of Oridonin Based on CNKI


[1] XIE Z, YU H, SUN X, et al. A novel diterpenoid suppresses osteoclastogenesis and promotes osteogenesis by inhibiting Ifrd1- and IκBα-Mediated p65 nuclear translocation[J]. Journal of Bone and Mineral Research,2018,33(4):667-678.

[2] 李春雨,王琪,申珅,等.冬凌草甲素对人黑色素瘤A375细胞侵袭和转移的影响及机制研究[J].中草药,2018,49(3):658-662.

[3] XU J, WOLD E A, DING Y, et al. Therapeutic potential of oridonin and its analogs:from anticancer and antiinflammation to neuroprotection[J]. Molecules,2018,23(2):474.

[4] HUANG W, HUANG M, OUYANG H, et al. Oridonin inhibits vascular inflammation by blocking NF-κB and MAPK activation[J]. European Journal of Pharmacology,2018,826:133-139.

[5] OH H N, SEO J H,LEE M H, et al. Oridonin induces apoptosis in oral squamous cell carcinoma probably through the generation of reactive oxygen species and the p38/JNK MAPK pathway[J]. Int J Oncol,2018,52(5):1749-1759.

[6] 戴一,仲飞.冬凌草甲素的结构修饰与生物活性研究进展[J].有机化学,2017,37(7):1701-1713.

[7] ZHANG Y W, BAO M H, LOU X Y, et al. Effects of oridonin on hepatic cytochrome p450 expression and activities in PXR-humanized mice[J]. Biol Pharm Bull,2018,41(5):707-712.

[8] DING Y, LI D, DING C, et al. Regio- and stereospecific synthesis of oridonin d-ring aziridinated analogues for the treatment of triple-negative breast cancer via mediated irreversible covalent warheads[J]. Journal of Medicinal Chemistry,2018,61(7):2737- 2752.

[9] YANG J, REN X, ZHANG L, et al. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway[J]. Biomed Pharmacother, 2018,100:226-232.

[10] 徐蕴,魏琦,汤大朋,等.2006—2015年中国期刊全文数据库中医基础理论研究文献计量分析[J].中医杂志,2017,58(5):418-422.

[11] 刘劲松.提升学术期刊论文下载与被引频次的思考—基于刊后论文跟踪分析及办刊实践[J].西南石油大学学报:社会科学版,2016,18(4):63-68.

[12] 刘建勋.中药新药药效学实验研究方法与要求[J].中药新药与临床药理,1998,9(2):49-52.

[13] DING, Y, DING C Y, YE N, et al. Discovery and development of natural product oridonin-inspired anticancer agents[J]. Eur J Med Chem,2016,122:102-117.